Rheumatology International

期刊简介：RHEUMATOLOGY INTERNATIONAL is an independent journal reflecting world-wide progress in the research, diagnosis and treatment of the various rheumatic diseases. It is designed to serve researchers and clinicians in the field of rheumatology.RHEUMATOLOGY INTERNATIONAL will cover all modern trends in clinical research as well as in the management of rheumatic diseases. Special emphasis will be given to public health issues related to rheumatic diseases, applying rheumatology research to clinical practice, epidemiology of rheumatic diseases, diagnostic tests for rheumatic diseases, patient reported outcomes (PROs) in rheumatology and evidence on education of rheumatology. Contributions to these topics will appear in the form of original publications, short communications, editorials, and reviews. "Letters to the editor" will be welcome as an enhancement to discussion. Basic science research, including in vitro or animal studies, is discouraged to submit, as we will only review studies on humans with an epidemological or clinical perspective. Case reports without a proper review of the literatura (Case-based Reviews) will not be published. Every effort will be made to ensure speed of publication while maintaining a high standard of contents and production.Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.

【译文】《风湿病学国际》是一本反映全球风湿病研究、诊断和治疗进展的独立期刊。它旨在为风湿病学领域的研究人员和临床医生提供服务。该期刊将涵盖临床研究以及风湿病管理的所有现代趋势。特别强调与风湿病相关的公共卫生问题，将风湿病学研究应用于临床实践，风湿病的流行病学，风湿病的诊断测试，风湿病学中的患者报告结果（PROs）以及风湿病学教育方面的证据。这些主题的贡献将以原创出版物、简报、社论和综述的形式出现。欢迎以增强讨论为目的的“致编辑信”。不鼓励提交基础科学研究，包括体外或动物研究，因为我们只审查具有流行病学或临床视角的人类研究。没有适当文献综述的病例报告（基于病例的综述）将不予发表。我们将尽一切努力确保出版速度的同时保持内容和生产的高标准。提交出版的手稿必须包含一份声明，说明所有人类研究都已由适当的伦理委员会审查，因此已按照1964年赫尔辛基宣言的适当版本中规定的伦理标准进行。应在文本中明确说明，所有受试者在被纳入研究之前都提供了知情同意。应省略可能泄露正在研究中的受试者身份的细节。